↓ Skip to main content

PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, September 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
84 Mendeley
Title
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer
Published in
Journal of Cancer Research and Clinical Oncology, September 2011
DOI 10.1007/s00432-011-1049-2
Pubmed ID
Authors

Chenfang Zhu, Xiaoliang Qi, Yaning Chen, Bo Sun, Yalei Dai, Yan Gu

Abstract

To investigate the signaling pathways involved in insulin-like growth factor-1 (IGF-1)-induced vascular endothelial growth factor C (VEGF-C) up-regulation and lymphatic metastasis in MDA-MB-231 breast cancer cells.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 1%
Japan 1 1%
Russia 1 1%
Austria 1 1%
Unknown 80 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 25 30%
Student > Master 16 19%
Student > Bachelor 8 10%
Student > Postgraduate 7 8%
Researcher 6 7%
Other 8 10%
Unknown 14 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 31 37%
Medicine and Dentistry 15 18%
Biochemistry, Genetics and Molecular Biology 10 12%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Nursing and Health Professions 1 1%
Other 5 6%
Unknown 18 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2011.
All research outputs
#15,508,795
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#1,408
of 2,632 outputs
Outputs of similar age
#88,177
of 127,962 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#10
of 15 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,962 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.